// App-Quantinova.ai

: EXPLORING THE REAL-LIFE CLINICAL VALUE OF LOW DOSE DIRECT ANTICOAGULANTS FOR SECONDARY PREVENTION OF THROMBOEMBOLISM

Researchers

Presenter

  • Shiv Saul

Principal Investigators

  • Graham McIlroy

  • Neil Smith

  • Damian Perrin

  • Susan Fair

  • Charalampos Kartsios

Medical Centers

  • Haematology,Birmingham Heartlands Hospital,BIRMINGHAM,United Kingdom

  • Acute Medicine,Good Hope Hospital,BIRMINGHAM,United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

  • Cardiovascular (CVS)

  • Oncology (ONC)

Disease

  • Venous thrombosis

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • rivaroxaban

  • apixaban

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved